Biogen Intercontinental Region
From Brazil to China and Japan, Biogen's Intercontinental Region delivers new medicines that transform patients’ lives around the world. We offer partners established infrastructure and deep expertise in rare disease and specialty care. Connect with us at partnering@biogen.com
Beyond Biogen’s presence in North America and Europe, our established Intercontinental region serves over 80 additional countries across Brazil, Latin America (LATAM), Eastern Europe, the Middle East and Africa (MEA), Japan, China and throughout Asia Pacific (APAC).
Founded in 1978, Biogen is one of the world's first global biotech companies and a leader in rare disease. Our expertise enables us to navigate highly complex health ecosystems with excellence. By leveraging our regional core capabilities and global footprint, we can maximize the reach and impact of late-stage assets through tailored collaborations.
Commercial execution
Deep customer-facing expertise and scalable omnichannel excellence
Patient access
Expertise in global regulatory and reimbursement approaches to accelerate patient access to our treatments
Scientific leadership
Deliver practice changing evidence and education
Manufacturing power
World-class technology and engineering capabilities